Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial

The state of immune activation may guide targeted immunotherapy in sepsis. In a double-blind, double-dummy randomized clinical study, 240 patients with sepsis due to lung infection, bacteremia, or acute cholangitis were subjected to measurements of serum ferritin and HLA-DR/CD14. Patients with macro...

Descripción completa

Detalles Bibliográficos
Autores principales: Leventogiannis, Konstantinos, Kyriazopoulou, Evdoxia, Antonakos, Nikolaos, Kotsaki, Antigone, Tsangaris, Iraklis, Markopoulou, Dimitra, Grondman, Inge, Rovina, Nikoleta, Theodorou, Vassiliki, Antoniadou, Eleni, Koutsodimitropoulos, Ioannis, Dalekos, George, Vlachogianni, Glykeria, Akinosoglou, Karolina, Koulouras, Vassileios, Komnos, Apostolos, Kontopoulou, Theano, Prekates, Athanassios, Koutsoukou, Antonia, van der Meer, Jos W.M., Dimopoulos, George, Kyprianou, Miltiades, Netea, Mihai G., Giamarellos-Bourboulis, Evangelos J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729870/
https://www.ncbi.nlm.nih.gov/pubmed/36384100
http://dx.doi.org/10.1016/j.xcrm.2022.100817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729870/
https://www.ncbi.nlm.nih.gov/pubmed/36384100
http://dx.doi.org/10.1016/j.xcrm.2022.100817

Ejemplares similares